The medical technology space has grown by leaps and bounds over the course of the past few years has managed to attract considerable attention from investors. If you are currently looking into a stock from the sector then you could look into the Motus GI Holdings Inc (NASDAQ:MOTS) stock.
Trading Data
On Monday, MOTS stock jumped 3.58% to $0.4402 with more than 42.73 million shares, compared to its average volume of 844k shares. The stock moved within a range of $0.4400 – 0.6500 after opening trade at $0.5920.
Major Details
The stock was in considerable focus yesterday and ended the day with gains of 4%. That rally took the gains over the course of the past week to as much as 11%. Hence, the stock could in fact come into focus among investors today.
The rally in the Motus GI Holdings stock on Monday was primarily triggered by the news that the company had been awarded a 510(k) clearance for its Pure-Vu R EVS by the United States Food and Drug Administration. It was a major new development for the company and the reaction of the market participants was perhaps understandable.
However, it is going to be interesting to see if the stock can actually maintain its momentum and add to its gains over the coming days. It may be a good time for investors to add the stock to their watch lists and keep an eye on developments.
Key Quote
“My experience with the Pure-Vu Gen2 system has allowed me to treat and diagnose patients who otherwise would have been delayed. The new Pure-Vu EVS ergonomics are much better than the current version. The oversleeve and the scope feel much more integrated and it is easier to torque the scope, offering significantly improved navigation.”
Technical Data
MOTS stock is trading below the 50-Day and 200-Day Moving averages of $0.45 and $0.74 respectively. However, the stock is above 200-Day moving average of $0.41.
